Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
75.0%
% of BBH's 26 holdings also in FBT
60.0%
% of FBT's 31 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
ARGENX SE ADR | 5.8% | 3.4% | 3.4% |
 |
REGENERON PHARMACEUTICALS | 5.2% | 3.4% | 3.4% |
|
VERTEX PHARMACEUTICALS INC | 12.6% | 3.4% | 3.4% |
|
GILEAD SCIENCES INC | 13.2% | 3.4% | 3.4% |
|
NATERA INC | 5.2% | 3.3% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to FBT
|
AMGEN INC | 13.2% |
|
GILEAD SCIENCES INC | 9.9% |
|
VERTEX PHARMACEUTICALS INC | 9.2% |
|
IQVIA HOLDINGS INC | 4.0% |
 |
ICON PLC | 3.2% |
|
INSMED INC | 2.7% |
|
ARGENX SE ADR | 2.4% |
|
NATERA INC | 1.9% |
|
REGENERON PHARMACEUTICALS | 1.8% |
|
BIO-TECHNE CORPORATION | 1.7% |
BBH Underweight Relative to FBT
 |
GENMAB A/S SPONSORED ADR | -3.5% |
|
EXELIXIS INC | -3.4% |
|
KRYSTAL BIOTECH, INC. | -3.4% |
|
UNITED THERAPEUTICS CORP | -3.4% |
|
ACADIA PHARMACEUTICALS INC | -3.4% |
|
ALKERMES PLC | -3.3% |
|
WATERS CORP | -3.3% |
|
VERACYTE INC | -3.3% |
|
HALOZYME THERAPEUTICS INC | -3.2% |
 |
METTLER-TOLEDO INTERNATIONAL | -3.2% |